Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MERLIN-TIMI 36: Ranolazine in NSTE-ACS
NCT00099788Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Oct 2004
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ranolazine in non-ST elevation acute coronary syndrome (NSTE-ACS), sponsored by Gilead Sciences. Started Oct 2004; status: completed.
02
Drugs
ranolazine
03
Conditions
non-ST elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on NCT00099788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00099788.